The role of genetic polymorphism and other factors on clopidogrel resistance (Cr) in an asian population with coronary heart disease (chd)

• Main Authors: Akkaif, MA, Daud, NAA, Sha’aban, A, Ng, ML, Abdul Kader, MAS, Noor, DAM, Ibrahim, B
• Other Authors: MEDICINE
• Format: Review
• Published: MDPI AG 2021
• Subjects: CYP2C19 polymorphism 5; antiplatelet 3; clopidogrel 2; clopidogrel resistance 4; personalized medicine; Alleles; Asia; Asian Continental Ancestry Group; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Disease Management; Drug Interactions; Drug Resistance; Female; Humans; Male; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Population Surveillance; Purinergic P2Y Receptor Antagonists; Risk Assessment; Risk Factors
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/207197
• Institution: National University of Singapore

10.3390/molecules26071987